Financial Architects (New Jersey)’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Financial Architects (New Jersey)’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-600	Closed	-$7K	–	1678
2016 Q4	$7K	Buy	600 +100	+20%	+$1.2K	﹤0.01%	1110
2016 Q3	$7K	Hold	500	–	–	﹤0.01%	1091
2016 Q2	$4K	Buy	+500	New	+$3.75K	﹤0.01%	1190
2015 Q3	–	Sell	-6,000	Closed	-$50K	–	1137
2015 Q2	$50K	Buy	+6,000	New	+$53.1K	0.02%	441

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Financial Architects (New Jersey)'s ARIA Position: Q1 2017 in Review

Financial Architects (New Jersey) sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 600 shares — an estimated $7K sold.

Financial Architects (New Jersey) first reported a position in ARIA in Q2 2015 and held it in 4 quarters. The position peaked at $50K in Q2 2015. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Financial Architects (New Jersey) reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Financial Architects (New Jersey) sold 600 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $7K.
Financial Architects (New Jersey) first reported a position in Ariad Pharmaceuticals Inc in Q2 2015 and held it in 4 quarters.
Financial Architects (New Jersey)'s Ariad Pharmaceuticals Inc position peaked at $50K in Q2 2015.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2017, filed 26 Apr 2017.